Stuttgart - Delayed Quote • EUR Addex Therapeutics Ltd (APE1.SG) Follow Compare 7.85 +0.70 +(9.79%) As of 4:11:45 PM GMT+1. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for APE1.SG 1D 5D 18.05% 1M 20.77% 3M -22.28% 6M 15.44% YTD 12.95% 1Y -23.79% 5Y -95.64% All -95.64% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: APE1.SG View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Addex to Present at the 2025 Swiss Equities Baader Conference Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024 Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration Addex’s Partner Discontinues ADX71149 development in Epilepsy Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS) Addex To Present at the Thirteenth London International Cough Symposium (13th LICS) Addex Shareholders Approve All Resolutions at Annual General Meeting Related Tickers AM6.F Amicus Therapeutics, Inc. 9.05 -1.09% UBX Unity Biotechnology, Inc. 2.0800 -12.61% IBRX ImmunityBio, Inc. 3.1500 -0.63% RXRX Recursion Pharmaceuticals, Inc. 7.10 -3.20% MRNA Moderna, Inc. 42.84 +3.45%